
Noteless, an AI company changing how doctors handle patient documentation, has closed a €3.5 million seed funding round. Redstone led the investment as a new backer, with continued support from Futurum Ventures and Farvatn Venture.
The Oslo-based startup plans to use the capital to expand its clinical documentation platform across European markets, building on rapid adoption in Scandinavia where it now supports over 100,000 patient consultations weekly.
Medical paperwork has become a major pain point in healthcare systems across Europe. Doctors spend hours each day on administrative tasks instead of treating patients, contributing to widespread burnout and staff shortages that are putting pressure on already strained health systems.
Noteless tackles this problem with an AI scribe that generates medical notes automatically during patient consultations. The platform uses speech recognition and natural language processing to create accurate documentation in real time, giving clinicians back up to two hours daily.
"We've seen incredible adoption in the Nordics, where more than one in four general practitioners now use Noteless in Norway, and one in seven in Denmark," said William Vossgård, CEO and co-founder of Noteless. "Clinicians tell us we're giving them back up to two hours a day, time they can spend with patients or on their own wellbeing. This investment will help us bring that impact to clinicians across Europe."
Since launching its first product in June 2024, Noteless has processed over 3 million consultations. The company's paying customer base has grown by more than 360% since the start of the year, now serving around 3,000 clinicians across Norway, Denmark, and newer markets including the UK, Germany, and the Netherlands.
The fresh funding will support continued product development and European expansion, with particular focus on entering the DACH region. Noteless is also seeing growing interest from specialists beyond general practice, with physiotherapists, psychologists, and specialist doctors adopting the platform to reduce their documentation workload.
Founded in October 2023, Noteless has established itself as one of Scandinavia's fastest-growing healthtech companies. The startup now employs 35 people across Norway, Denmark, and the Netherlands, with plans to continue hiring as it scales operations across Europe.
The idea for Noteless came from CEO William Vossgård's firsthand observations of how much time doctors waste on paperwork instead of caring for patients. He recruited two co-founders who shared his vision: Mikkel Dahl Slettebø, who left his master's studies in Artificial Intelligence to join full-time, and Sarankan Sivakanesan, a medical doctor who stepped away from his specialization training to tackle the problem directly. Within months, the team built a working product that validated immediately with Norwegian GPs who were desperate for a solution.
The company's appeal lies in solving a problem that affects healthcare workers across the continent. Europe faces severe healthcare staffing challenges, with documentation workload being a major contributor to professional burnout and attrition.
"Noteless is solving one of the biggest inefficiencies in healthcare through AI-driven technology," said Lucas Paul, Investment Director at Redstone. "The company's innovative approach and rapid adoption show it is well-positioned to redefine clinical documentation across Europe."
Redstone joins as the lead investor in this seed round, bringing more than just capital to the table. As a Germany-based, healthtech-focused VC with influential limited partners and deep networks across the DACH region, Redstone provides direct support on market entry, regulatory navigation, and establishing key partnerships. Their strong regional presence makes them a particularly valuable partner as Noteless scales beyond the Nordics.
Existing investors Futurum Ventures and Farvatn Venture participated in the round, continuing their backing of the company since its inception. The startup's growth trajectory and market validation have attracted investors who see potential in addressing one of healthcare's most pressing operational challenges through artificial intelligence.

